Abstract
Bladder augmentation is indicated in patients that have failed conservative measures for poor bladder compliance, small capacity bladder, or refractory detrusor overactivity. New therapies, including intradetrusor onabotulinumtoxinA injections, have decreased the role of bladder augmentation, but in well-selected patients augmentation can lead to improved continence and quality of life. Nonetheless, complications are not uncommon following augmentation cystoplasty and include recurrent urinary tract infections, stones, metabolic disturbances, malignancy, and augment perforation. This chapter aims to assist the clinician to recognize, prevent, and manage both the short- and long-term complications of bladder augmentation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
